Second Sight Medical Products Inc. closed up more than 27 percent after announcing the results of a two-year study of its Orion visual prosthesis.
A stomach cancer drug in development by Amgen Inc. has been granted Breakthrough Therapy Designation by the U.S. Food and Drug Administration.
Medtronic has launched its diabetes extended infusion set in some European countries.
Assisted living facility chain Silverado Senior Living has opened its newest memory care center in Thousand Oaks, its first location in Ventura County.
Second Sight Medical Products announced its Argus IIs Retinal Prosthesis System was approved by the U.S. Food and Drug Administration.
Amgen Inc. plans to acquire Bay Area biotech company Five Prime Therapeutics for $1.9 billion in cash, or $38 per share.
The City of Lancaster, in partnership with Kaiser Permanente, will open a mass vaccination site at the Antelope Valley Fairgrounds on March 8.
MannKind Corp. on Monday announced it intends to offer a private placement of convertible senior notes worth $150 million.
MannKind Corp. touted increased sales for its flagship drug Afrezza during its fourth quarter earnings report, while pointing out its new direction toward therapies for lung and endocrine diseases.
Brent Reinke, partner at Musick Peeler Law Firm in Westlake Village, will join Stradling Yocca Carlson and Rauth as a corporate shareholder.
Health Net, the medical insurer in Woodland Hills, has partnered with L.A.-based nonprofit Wesley Health Centers to conduct a study assessing the impact of the COVID-19 pandemic on racial minorities.
An emergency field hospital erected in the parking lot of Antelope Valley Hospital officially closed.
Arcutis Biotherapeutics reported robust business progress in conjunction with its fourth-quarter earnings report.
The state government is actively investigating poor management allegations at a PerkinsElmer COVID-19 testing laboratory in Valencia.